127
Views
10
CrossRef citations to date
0
Altmetric
Original Article

The Prognostic Value of Estrogen and Progesterone Receptors in Female Breast Cancer. A Single Center Study

, , , &
Pages 691-695 | Received 20 May 1990, Accepted 22 Feb 1991, Published online: 05 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sirpa Aaltomaa, Perth Lipponen & Matti Eskelinen. (1992) Demographic Prognostic Factors in Breast Cancer. Acta Oncologica 31:6, pages 635-640.
Read now

Articles from other publishers (9)

Michael Press, Betsy Spaulding, Susan Groshen, David Kaminsky, Margaret Hagerty, Lori Sherman, Kurt Christensen & Dean P Edwards. (2002) Comparison of different antibodies for detection of progesterone receptor in breast cancer. Steroids 67:9, pages 799-813.
Crossref
D. Nikolic-Vukosavljevic, K. Kanjer, Z. Neskovic-Konstantinovic & D. Vukotic. (2018) Natural History of Estrogen Receptor-Negative, Progesterone Receptor-Positive Breast Cancer. The International Journal of Biological Markers 17:3, pages 196-200.
Crossref
D Coradini, S Oriana, L Mariani, R Miceli, G Bresciani, E Marubini & G Di Fronzo. (1998) Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour?. European Journal of Cancer 34:6, pages 825-830.
Crossref
K. Collett, R. Skjærven & B.O. Mæhle. (1998) The prognostic contribution of estrogen and progesterone receptor status to a modified version of the Nottingham Prognostic Index. Breast Cancer Research and Treatment 48:1, pages 1-9.
Crossref
K Collett, F Hartveit, R Skjaerven & B O Maehle. (1996) Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status.. Journal of Clinical Pathology 49:11, pages 920-925.
Crossref
Kirby I. Bland. (1995) The Emerging Importance of Molecular Biology in the Therapy of Breast Carcinoma. The Breast Journal 1:3, pages 125-127.
Crossref
Daniel F. Hayes. (1994) Tumor Markers for Breast Cancer: Current Utilities and Future Prospects. Hematology/Oncology Clinics of North America 8:3, pages 485-506.
Crossref
D.F. Hayes. (1993) Tumor markers for breast cancer. Annals of Oncology 4:10, pages 807-819.
Crossref
S. Aaltomaa, P. Lipponen, S. Papinaho & K. Syrj�nen. (1993) Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer. Journal of Cancer Research and Clinical Oncology 119:5, pages 288-294.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.